NCT00360269View on ClinicalTrials.gov

Atomoxetine Treatment for ADHD and Marijuana Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Marijuana AbuseAttention Deficit Disorder With Hyperactivity
Interventions
DRUG

Atomoxetine

25 to 100 mg daily

PROCEDURE

Motivational enhancement therapy

Three sessions

DRUG

Placebo

25 to 100 mg daily

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Medical University of South Carolina

OTHER

NCT00360269 - Atomoxetine Treatment for ADHD and Marijuana Dependence | Biotech Hunter | Biotech Hunter